QualityMetric’s PRO health surveys

The validity, precision, versatility, and utility of QualityMetric's comprehensive product portfolio have made our surveys the most accurate and widely used patient-reported outcome (PRO) measurement tools in the global healthcare market.

In addition to providing the initial assessment of an individual's health status, our surveys can evaluate treatment effectiveness, differentiate between outcomes produced by a wide range of treatments, enable evaluation of treatment benefits in relation to health costs and utilization of services, and meaningfully engage the consumer in the healthcare process.

Our high-value health status surveys can be used in pharmacoeconomic analysis, clinical trials, direct-to-consumer (DTC) marketing, disease and population management, risk assessment, cost prediction, and consumer-directed healthcare initiatives.

Our suite of PRO surveys

Available in over 2,000 languages across multiple modes of administration.

PRO Assessments

For assessing patients’ quality of life and functional health and well-being across all conditions.

SF-36v2^® Health Survey SF-12v2^® Health Survey SF-12v2^® Health Survey–MH Enhanced™ SF-12v2^® Health Survey–Pain Enhanced™ SF-12v2^® Health Survey–Crisis Impact™ The SF-6Dv2^® Health Utility Consumer Health Activation Index (CHAI) MOS-Sleep Scale-Revised MOS-Cognitive Functioning Scale Revised Pain Impact Questionnaire™ (PIQ-6™)

Disease-Specific Surveys

For measuring a patient’s functional health and well-being as it is affected or influenced by a particular condition or disease.

Asthma Control Test™ (ACT™) Asthma Control Test™ – Caregiver Asthma Impact Survey™ (AIS-6™) COPD Population Screener™ (COPD-PS™) Headache Impact Test™ (HIT-6™) Hepatitis Quality of Life™ (HQLQv2™) Premenstrual Symptoms Impact Survey™
(PMSIS™) Rhinitis Impact Survey™ (RIS-6™)

Pediatric-Specific Surveys

For evaluating a child’s general health as well as the effect of certain diseases on their quality of life.

SF-10 Health Survey for Children™ Pediatric Asthma Impact Survey™ (PAIS-6™)

Fit-for-Purpose Surveys

For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.

Custom Surveys

For measurement that is specific to your project or condition-related goals, whether you require an entirely new PRO survey or modifications to an existing survey.

Learn More

Enhancing your decision-making processes

Our high-quality, regulatory-compliant data will better inform your processes and improve your ability to address health-related outcomes.

DRUG PERFORMANCE

Measure and monitor the effectiveness of treatments, medical devices and programs over time.

DISEASE BURDEN

Understand the full impact of diseases on patients and defined populations.

COMPARATIVE EFFECTIVENESS:

Make risk-adjusted comparisons across treatments, providers, programs, and patients.

PATIENT LIFECYCLE

Evaluate unmet needs and identify opportunities to increase the length and quality of patients’ lives.

FUTURE RISKS

Predict the future health utilization and medical expenditures of certain patients.

HEALTH FLUCTUATION

Measure and monitor health improvement or decline as well as the velocity of change over time.

LABEL CLAIMS

Assess the accuracy of label and marketing claims and better meet regulatory requirements.

Benefiting the product lifecycle

Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.

Commercial

Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.

Phase I

Assist with PRO/COA and clinical end development; outcome measures selection; the review and synthesis of evidence for specific measures; and the development and psychometric evaluation of new measures for testing in Phase II.

Phase II

Assist with preparation for End of Phase 2 meetings; COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.

Phase III

Assist with COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.

Phase IV

Assist with strategy, design, endpoints, and analysis for real-world studies; Electronic Data Capture solution for real-world studies; analysis and interpretation of PRO results; Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.

Registries

Develop measurement strategy that contributes to the body of evidence for all stakeholders. Characterize and quantify treatment benefit using PRO, ClinRO, ObsRO.